Category

CDRD

adMare BioInnovations Appoints Dr. Youssef Bennani as Venture Partner

By CDRD, News & Events

With more than 25 years of experience in pharmaceutical R&D leadership and management, serving most recently as Site Head and VP of R&D at Vertex Pharmaceuticals Canada Inc., Dr. Bennani will be based in Montreal, and responsible for overseeing and advancing a portfolio of drug development and commercialization projects through management of a multi-disciplinary scientific and business team.

Read More

CDRD & TRIUMF Announce Collaboration to Revolutionize the Fight Against Cancer with Targeted Alpha Therapy

By CDRD, News & Events

By combining TRIUMF’s expertise in manufacturing isotopes and radiolabelling conjugates with CDRD’s ability to identify and validate potential biological targets to develop therapeutic agents such as monoclonal antibodies, new “weaponized targeted therapies” can be created for the treatment of cancers with significant unmet medical need. In doing so, the organizations are leveraging two of Canada’s complementary national strengths to create a unique global competitive advantage; while also enabling an integrated health sciences ecosystem that bridges the gap between academic research, commercialization, and patient care in targeted alpha therapeutics.

Read More

Canadian Life Sciences Leaders Come Together to Discuss and Support Recommendations within the Federal Government’s Health and Biosciences Economic Strategy Table Report

By CDRD, News & Events

To exemplify the collaborative spirit and leadership needed to advance the Canadian health and biosciences sector, Canadian life sciences leaders – CDRD, LifeSciences BC, TRIUMF Innovations and BIOTECanada – are hosting an event today to build support and encourage action and agreement that will advance recommendations from The Government of Canada’s Health and Biosciences Economic Strategy Table Report.

Read More